Determinants of quality of life of patients with heart failure and iron deficiency treated with ferric carboxymaltose: FAIR-HF sub-analysis.

@article{Gutzwiller2013DeterminantsOQ,
  title={Determinants of quality of life of patients with heart failure and iron deficiency treated with ferric carboxymaltose: FAIR-HF sub-analysis.},
  author={Florian S. Gutzwiller and Alena M. Pfeil and Josep Com{\'i}n-Colet and Piotr P Ponikowski and Gerasimos Filippatos and Claudio Mori and Peter G. Braunhofer and Thomas D. Szucs and Matthias Schwenkglenks and Stefan D. Anker},
  journal={International journal of cardiology},
  year={2013},
  volume={168 4},
  pages={3878-83}
}
BACKGROUND Heart failure (HF) is a burden to patients and health care systems. The objectives of HF treatment are to improve health related quality of life (HRQoL) and reduce mortality and morbidity. We aimed to evaluate determinants of health-related quality of life (HRQoL) in patients with iron deficiency and HF treated with intravenous (i.v.) iron substitution or placebo. METHODS A randomised, double-blind, placebo-controlled trial (n = 459) in iron-deficient chronic heart failure (CHF… CONTINUE READING
9 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…